Skip to main content
Premium Trial:

Request an Annual Quote

Watson Extends its Reach

Premium

Clinicians and researchers at Memorial Sloan-Kettering Cancer Center have a new weapon in their cancer-fighting arsenal — IBM's Watson supercomputer. IBM and Sloan-Kettering are collaborating on the development of a new service featuring Watson, reports Bloomberg's Beth Jinks. The computer will assist doctors in making diagnoses and treatment decisions by mining current information and alerting doctors to new developments and research, Jinks says. A statement from Sloan-Kettering and IBM calls the Watson service a "decision support tool," and says it gives doctors access to much more information than they could possibly gather by themselves. "Watson is being taught oncology and being programmed with the types of questions it will be posed in a similar way to when it was trained for 'Jeopardy!'" Jinks says. "Sloan-Kettering and IBM are already developing the first applications using Watson related to lung, breast, and prostate cancers, and aim to begin piloting the solutions to some oncologists in late 2012, with wider distribution planned for late 2013."

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.